Measures to define chronic kidney disease - In reply

JAMA

Volumn 309, Issue 13, 2013, Pages 1343-1344

  Hallan, Stein I ^a   Matsushita, Kunihiro ^b   Coresh, Josef ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE;

ALBUMINURIA; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; COMORBIDITY; COST BENEFIT ANALYSIS; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; LETTER; LIFE EXPECTANCY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; CHRONIC KIDNEY FAILURE; FEMALE; KIDNEY; MALE; NOTE; PATHOPHYSIOLOGY;

ALBUMINURIA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE;

EID: 84875677337     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.1349     Document Type: Letter

References (3)

1. Uhlig K, Levey AS. Developing guidelines for chronic kidney disease: we should include all of the outcomes. Ann Intern Med. 2012;156(8):599-601.
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1-150.
3. Krumholz HM, Seeman TE, Merrill SS, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 1994;272(17):1335-1340. (Pubitemid 24323614)